Iradimed Total Assets Growth & History (IRMD)
Iradimed's total assets was $108.8M for fiscal 2025.
View full Iradimed company overviewIradimed annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $108.8M | $10.4M | +10.63% |
| 2024 | 2024-12-31 | $98.3M | $6.2M | +6.70% |
| 2023 | 2023-12-31 | $92.2M | $6.6M | +7.77% |
| 2022 | 2022-12-31 | $85.5M | $2.6M | +3.18% |
| 2021 | 2021-12-31 | $82.9M | $11.8M | +16.62% |
| 2020 | 2020-12-31 | $71.1M | $4.3M | +6.50% |
| 2019 | 2019-12-31 | $66.7M | $18.3M | +37.75% |
| 2018 | 2018-12-31 | $48.4M | $9.4M | +24.17% |
| 2017 | 2017-12-31 | $39.0M | $1.8M | +4.89% |
| 2016 | 2016-12-31 | $37.2M | $2.0M | +5.53% |
| 2015 | 2015-12-31 | $35.2M | $11.9M | +51.20% |
| 2014 | 2014-12-31 | $23.3M | $16.3M | +233.62% |
| 2013 | 2013-12-31 | $7.0M | — | — |
Iradimed quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $115.0M | $8.5M | +8.01% |
| Q1 2026 | 2026-03-31 | $114.4M | $12.7M | +12.44% |
| Q4 2025 | 2025-12-31 | $108.8M | $10.4M | +10.63% |
| Q3 2025 | 2025-09-30 | $114.7M | $20.5M | +21.72% |
| Q2 2025 | 2025-06-30 | $106.4M | $16.5M | +18.34% |
| Q1 2025 | 2025-03-31 | $101.7M | $13.7M | +15.58% |
| Q4 2024 | 2024-12-31 | $98.3M | $6.2M | +6.70% |
| Q3 2024 | 2024-09-30 | $94.2M | $6.8M | +7.83% |
| Q2 2024 | 2024-06-30 | $89.9M | $8.5M | +10.46% |
| Q1 2024 | 2024-03-31 | $88.0M | $12.4M | +16.39% |
| Q4 2023 | 2023-12-31 | $92.2M | $6.6M | +7.77% |
| Q3 2023 | 2023-09-30 | $87.4M | $7.9M | +9.88% |
| Q2 2023 | 2023-06-30 | $81.4M | $5.7M | +7.54% |
| Q1 2023 | 2023-03-31 | $75.6M | $3.2M | +4.46% |
| Q4 2022 | 2022-12-31 | $85.5M | $2.6M | +3.18% |
| Q3 2022 | 2022-09-30 | $79.5M | $1.1M | +1.46% |
| Q2 2022 | 2022-06-30 | $75.7M | $144,238 | +0.19% |
| Q1 2022 | 2022-03-31 | $72.4M | $204,573 | +0.28% |
| Q4 2021 | 2021-12-31 | $82.9M | $11.8M | +16.62% |
| Q3 2021 | 2021-09-30 | $78.4M | $8.0M | +11.32% |
| Q2 2021 | 2021-06-30 | $75.6M | $6.8M | +9.81% |
| Q1 2021 | 2021-03-31 | $72.2M | $3.8M | +5.59% |
| Q4 2020 | 2020-12-31 | $71.1M | $4.3M | +6.50% |
| Q3 2020 | 2020-09-30 | $70.4M | $7.9M | +12.55% |
| Q2 2020 | 2020-06-30 | $68.8M | $12.0M | +21.07% |
| Q1 2020 | 2020-03-31 | $68.4M | $14.0M | +25.65% |
| Q4 2019 | 2019-12-31 | $66.7M | $18.3M | +37.75% |
| Q3 2019 | 2019-09-30 | $62.6M | $15.8M | +33.67% |
| Q2 2019 | 2019-06-30 | $56.8M | $14.0M | +32.72% |
| Q1 2019 | 2019-03-31 | $54.4M | $14.2M | +35.15% |
| Q4 2018 | 2018-12-31 | $48.4M | $9.4M | +24.17% |
| Q3 2018 | 2018-09-30 | $46.8M | $8.9M | +23.45% |
| Q2 2018 | 2018-06-30 | $42.8M | $6.0M | +16.25% |
| Q1 2018 | 2018-03-31 | $40.3M | $2.8M | +7.60% |
| Q4 2017 | 2017-12-31 | $39.0M | $1.8M | +4.89% |
| Q3 2017 | 2017-09-30 | $37.9M | $2.4M | +6.85% |
| Q2 2017 | 2017-06-30 | $36.8M | $4.5M | +13.90% |
| Q1 2017 | 2017-03-31 | $37.4M | $4.0M | +11.86% |
| Q4 2016 | 2016-12-31 | $37.2M | $2.0M | +5.53% |
| Q3 2016 | 2016-09-30 | $35.5M | $4.4M | +14.29% |
| Q2 2016 | 2016-06-30 | $32.3M | $3.6M | +12.47% |
| Q1 2016 | 2016-03-31 | $33.5M | $7.4M | +28.60% |
| Q4 2015 | 2015-12-31 | $35.2M | $11.9M | +51.20% |
| Q3 2015 | 2015-09-30 | $31.1M | $8.6M | +38.55% |
| Q2 2015 | 2015-06-30 | $28.8M | $18.8M | +189.45% |
| Q1 2015 | 2015-03-31 | $26.0M | — | — |
| Q4 2014 | 2014-12-31 | $23.3M | $16.3M | +233.62% |
| Q3 2014 | 2014-09-30 | $22.4M | — | — |
| Q2 2014 | 2014-06-30 | $9.9M | — | — |
| Q4 2013 | 2013-12-31 | $7.0M | — | — |
Iradimed total assets trends
Over the last five fiscal years, Iradimed's total assets increased from $71.1M to $108.8M, a change of $37.7M. The latest reported quarter, Q2 2026, shows $115.0M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Iradimed source filings ↗